Dr. Scott Schuetze, MD, PhD
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Liposarcoma
Studies Soft Tissue Sarcoma
10 reported clinical trials
16 drugs studied
Area of expertise
1Liposarcoma
Stage IV
Stage III
MDM2 positive
2Soft Tissue Sarcoma
Stage IV
Stage III
FGFR positive
Affiliated Hospitals
Clinical Trials Scott Schuetze, MD, PhD is currently running
Adoptive Cell Therapy
for Cancer
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Recruiting1 award Phase 1
Cancer Vaccines
for Lynch Syndrome
This trial tests a vaccine and an immune booster to prevent cancer in people with Lynch syndrome. The vaccine teaches the body to fight cancer, and the booster makes this process stronger. Vaccines have shown robust potential for preventing Lynch syndrome cancers.
Recruiting0 awards Phase 214 criteria
More about Scott Schuetze, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Scott Schuetze, MD, PhD has experience with
- Nivolumab
- Doxorubicin
- BI 907828
- Regorafenib
- Paclitaxel
- Rogaratinib
Breakdown of trials Scott Schuetze, MD, PhD has run
Liposarcoma
Soft Tissue Sarcoma
Cancer
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Schuetze, MD, PhD specialize in?
Scott Schuetze, MD, PhD focuses on Liposarcoma and Soft Tissue Sarcoma. In particular, much of their work with Liposarcoma has involved Stage IV patients, or patients who are Stage III.
Is Scott Schuetze, MD, PhD currently recruiting for clinical trials?
Yes, Scott Schuetze, MD, PhD is currently recruiting for 3 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Scott Schuetze, MD, PhD has studied deeply?
Yes, Scott Schuetze, MD, PhD has studied treatments such as Nivolumab, Doxorubicin, BI 907828.
What is the best way to schedule an appointment with Scott Schuetze, MD, PhD?
Apply for one of the trials that Scott Schuetze, MD, PhD is conducting.
What is the office address of Scott Schuetze, MD, PhD?
The office of Scott Schuetze, MD, PhD is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.